Documente Academic
Documente Profesional
Documente Cultură
الرحمن الرحيم
“قالوا ل علم لنا ال ما علمتنا
انك انت العليم الحكيم”
ANALYSIS OF CLINICAL
AND LABORATORY DATA OF
INFANTS AND CHILDREN
ADMITTED WITH ACUTE
RENAL FAILURE TO
DIALYSIS UNIT OF
ALEXANDRIA UNIVERSITY
CHILDREN’S HOSPITAL: TEN
YEARS EXPERIENCE
(1995-2004)
Definition of Acute Renal
Failure:
ARF is a syndrome with multiple causes;
defined as a sudden loss of renal functions (over
several hours to several days).
ARF results in derangement in extracellular
fluid balance, acid base, electrolytes and divalent
cation regulation.
An increase in serum creatinine
concentration, accumulation of other nitrogenous
waste products and often a decline in urinary output
are the hall marks of ARF.
Classification of ARF
•Radiological
•Laboratory Evaluation
Diagnosis
Physical Examination
• Vital signs: espec temp and BP
• Fluid status: mucous membranes, JVP, peripheral
edema
• CVS: murmur, pericardial rub, CHF
• Resp: rales consistent with edema
• Abdo: bladder distension, masses, ascites, CVA
tenderness
• Derm: rash
– Maculopapular: interstitial nephritis
– Purpura: vasculitis
– Petechiae: HUS/TTP.
Laboratory investigation
• Blood
– CBC-D
– Lytes, Ca, Mg, P
– Urea
– Creatinine
• Urine
– Urine sodium
– Urine osmolality
– Urinalysis Consists of:
– dipstick for heme pigment, protein, glucose, ketones,
pH, leukocytes, and nitrites
– Microscopic examination of urine
Radiological Investigations
• Radiology
– CXR
– Renal U/S
– CT
– IVP •
– Retrograde pyelogram
Other investigations
– ECG
– serum C3
– Antineutrophil cytoplasmic antibodies.
– Glomerular basement membrane antigens.
The most urgent aspects of
ARF are:
• Hyperkalaemia
• Severe hypertension
• Severe plasma and extracellular volume
expansion leading to heart failure and
pulmonary edema.
• Unremitting metabolic acidosis.
• Hypocalcemia / hyperphosphatemia.
• Uremia.
Therapy
i c t h er a py
o n-d i al y t
N
Dialysis:
Non-dialytic therapy
Growth factor.
Atrial Natriuretic Peptide (ANP)
Intra Cellular Adhesion Molecules
Anti oxidant therapy
Dopamine •
Mannitol
Diuretics •
Adjuvant Measures has to include
cardiorespiratory support, nutrition, prevention and
treatment of sepsis, and treatment of the condition that
precipitated the ARF.
Dialysis:
Indications of dialysis:
Severe derangements in electrolyte
concentrations .
Volume overload.
Acid-base imbalance.
Pronounced azotemia; blood urea
nitrogen >100mg/dl
Florid symptoms of uremia
(pericarditis,encephalopathy, bleeding,
nausea, vomiting or pruritus).
Dialysis:
• Hemodialysis :
Peritoneal Dialysis
Indications for Peritoneal Dialysis in
Acute Renal Failure
200
150
No. of cases
100
50
0
Neonate infant preschool school adolescent
0%
Female
40%
Male
60%
negative
family history
35%
urban
rural
65%
450
Oliguria or anuria
400
350
Volume overload
300
Gastrointestinal bleeding
No. of cases 250
Hypertension
Bleeding diasthesis
200
1 50
Heart failure
Convulsions
1 00
50
Coma
0
90
80
Oligo/anuria %
70
V. overload %
Hypertension % 60
Heart failure %
% 50
GIT. Bleeding %
40
Bl. Diasthesis %
Convulsions % 30
Coma %
20
10
0
Neonate Infant Preschool School Adolescent
Hepatitis profile of the patients
600
500
400
300
200
100
0
HBs Ag HBs Ag HCV Ab HCV Ab
negative positive positive negative
Results of renal biopsy in
patients with ARF.
14
Membranoproliferative GN
12 Rapidly progressive GN
Lupus nephritis
10 End stage renal disease
Nephronophthisis
8 ATN
Mesangioproliferative GN
Focal segmental GN
6
Acute interstitial nephritis
Renal tumour
4
Not adequate
Alport syndrome
2
Uric acid nephropathy
HUS
0
Ultrasonographic data of
cases.
Increased cortical echogenicity
Normal
200
60 Renal tumour/mass
0
Nephrocalcinosis
ultrasonographic finding
Results of VCUG done for some
cases with obstructive and/or
reflux nephropathy .
50
45
40
35
30
No. of cases 25
20
15
10
0
normal VUR PUV
Results of DMSA scan done for
some cases with obstructive and/or
reflux nephropathy.
60
50
40
No. of cases 30
20
10
0
normal renal scarring
Diagnosis of cases dialyzed for
ARF
Acute tubular/cortical necrosis
HUS
Congenital anomaly
Nephrotic syndrome
Unknow n
Rapidly progressive GN
Bilateral nephrolithiasis
Tumour lysis syndrome
SLE
Hepatorenal syndrome
Juvenile/f amilial nephronophthisis
Renal tumour
Uric acid nephropathy
Nephrocalcinosis
Renal trauma/nephrectomy
Distribution of cases with acute
tubular or cortical necrosis
90
80
70
60
50
No. of cases
40
30
20
10
0
sepsis gastroenteritis others
Fate of cases dialyzed for ARF
31.1%
died 39.7%
chronic 100
follow up
90
29.2%
80
70
60
Follow up %
% 50
Died %
Chronic % 40
30
20
10
0
Neonate Infant Preschool School Adolescent
Type of dialysis done for cases
with ARF
6% 1%
Peritoneal dialysis
Peritoneal/hem odialys is
Hem odialysis
93%
Distribution of cases as regards
their origin
450
400
350
300
Community acquired
Hospital acquired 250
ICU 200
NICU
150
100
50
0
Morbidity and mortality of cases
with ARF regarding their origin.
100
90
80
70
Community acquired 60
Hospital acquired % 50
PICU
40
NICU
30
20
10
0
Follow up % Died % Chronic %
From this study we concluded that:
ARF occured with an average of 50 cases / year.
Most of cases who presented with ARF were infants (37.9
% of cases ), followed by school age group (25 %). Male
patients out numbered female patients and patients from rural
areas out numbered those from urban areas.
Presence of family history of renal problems or renal
failure was absent in most of the studied patients.
The most common clinical findings at presentation in all
age groups were oligu/anuria and volume overload .
Most cases were HCV antibody negative and HBV surface
antigen negative at time of initiation of dialysis.
Most cases of ARF due to obstructive uropathy,
had primary VUR.
The most common causes of ARF were ATN,
obstructive uropathy, and hemolytic uremic
syndrome.
Mortality rate of acute renal failure is high
specially in neonates and in cases dialyzed in PICU.
Mortality rate in cases presenting with ARF due to
hepatorenal syndrome and renal tumours were the
highest.
APD was the standered modality of dialysis in our
unit, and it proved to have a highly accepted efficacy.